Robert Sikorski MD, PhD
South San Francisco, California, United States
4K followers
500+ connections
Woodside Way Ventures
Howard Hughes Medical Institute Fellowship, National Cancer Institute
About
Biotechnology executive with broad leadership and drug development experience in driving…
Articles by Robert
-
Five Prime Therapeutics Advances into Phase 1b Portion of Trial Evaluating the Immunotherapy Combination of Cabiralizumab (FPA008) and OPDIVO (nivolum
By Robert Sikorski MD, PhD
-
Five Prime Therapeutics Receives FDA Orphan Drug Designation for FPA144 for the Treatment of Gastric Cancer
By Robert Sikorski MD, PhD
-
Five Prime Therapeutics Presents Updated Data from Phase 1 trial of Single-Agent FPA144 at 2016 ASCO Annual Meeting
By Robert Sikorski MD, PhD
Activity
-
Congratulations to the Immusoft team for achieving this medical milestone.. https://lnkd.in/eVjC_Vgb
Congratulations to the Immusoft team for achieving this medical milestone.. https://lnkd.in/eVjC_Vgb
Shared by Robert Sikorski MD, PhD
-
SQZ scientists Kelan Hlavaty and Luke Cassereau have been at AACR the past few days presenting some exciting data on our oncology programs. We had a…
SQZ scientists Kelan Hlavaty and Luke Cassereau have been at AACR the past few days presenting some exciting data on our oncology programs. We had a…
Liked by Robert Sikorski MD, PhD
Experience
-
Woodside Way Ventures
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Education
-
-
-
-
-
-
-
-
-
-
Licenses & Certifications
-
Medical Oncology
American Board of Internal Medicine
-
Internal Medicine
American Board of Internal Medicine
Publications
-
Visualizing the Landscape of Selection Biomarkers in Current Phase III Oncology Clinical Trials
Science Translational Medicine
Courses
-
Hematology and Medical Oncology Best Practices - The George Washington University School of Medicine and Health Sciences
2013
Languages
-
Russian
-
Organizations
-
American Society of Clinical Oncology (2013)
Member
-
Society for Immunotherapy of Cancer (2013)
Member
More activity by Robert
A big day for Eidos! We're on our way to to making AG10 a safe and effective therapy for patients with ATTR. Many thanks to the many people who have…
A big day for Eidos! We're on our way to to making AG10 a safe and effective therapy for patients with ATTR. Many thanks to the many people who have…
Liked by Robert Sikorski MD, PhD
Free White Paper | Disrupting Study Start-Up: How Agile RTSM Software Development Accelerates the Clinical Trial Timeline
https://lnkd.in/drSY6YG
Free White Paper | Disrupting Study Start-Up: How Agile RTSM Software Development Accelerates the Clinical Trial Timeline https://lnkd.in/drSY6YG
Liked by Robert Sikorski MD, PhD
People also viewed
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More